DUSP6 (Dual Specificity Phosphatase 6), also known as MKP3 (Mitogen-Activated Protein Kinase Phosphatase 3), is a dual-specificity phosphatase that specifically dephosphorylates and inactivates ERK1/2 (Extracellular Signal-Regulated Kinases 1 and 2). Unlike other DUSP family members that target multiple MAPKs, DUSP6 exhibits high specificity for ERK1/2, making it a critical negative regulator of the RAS-RAF-MEK-ERK signaling pathway. The gene is located on chromosome 12p13 and encodes a 367-amino acid protein that is predominantly cytoplasmic and acts as a nuclear-excluded phosphatase. DUSP6 is catalogued as NCBI Gene ID 1848 and OMIM 601653.
| Dual Specificity Phosphatase 6 |
|---|
| Gene Symbol | DUSP6 |
| Alternative Names | MKP3, PYST1, CL100 |
| Full Name | Dual Specificity Phosphatase 6 |
| Chromosome | 12p13 |
| NCBI Gene ID | [1848](https://www.ncbi.nlm.nih.gov/gene/1848) |
| OMIM | 601653 |
| Ensembl ID | ENSG00000139318 |
| UniProt ID | [O43508](https://www.uniprot.org/uniprot/O43508) |
| Associated Diseases | Cancer, Developmental Disorders, Parkinson's Disease, Alzheimer's Disease |
DUSP6 contains characteristic dual-specificity phosphatase domains:
- N-terminal non-catalytic domain: Regulatory functions, protein interactions
- PTP domain (aa 95-340): Catalytic activity, substrate binding
- C-terminal region: ERK docking motif (D-site), subcellular localization
The protein has a classic PTP (protein tyrosine phosphatase) fold with the HCX5R active site motif essential for catalytic activity [@dusp6structure2019].
DUSP6 specifically dephosphorylates:
- ERK1/2 (Thr202/Tyr204): Primary substrate
- ERK5: Minor substrate
- Does NOT significantly dephosphorylate JNK or p38 MAPK
The enzyme shows 10-100 fold higher affinity for ERK1/2 compared to other DUSPs, making it the primary ERK-specific phosphatase in most cell types.
The high specificity for ERK1/2 is determined by:
- DUSP6 contains a kinase interaction motif (KIM) that specifically recognizes ERK
- The D-site docking motif binds ERK's common docking domain
- Steric constraints prevent access to larger MAPKs like JNK and p38
This specificity makes DUSP6 a precise "off switch" for ERK signaling.
DUSP6 is an immediate early gene induced by growth factors and stress:
- ERK activation induces DUSP6 transcription via AP-1 sites
- DUSP6 protein accumulates in the cytoplasm
- DUSP6 dephosphorylates active ERK1/2
- ERK signal is terminated in a negative feedback loop
This creates precise temporal control of ERK signaling duration.
DUSP6 is a critical regulator of Fibroblast Growth Factor (FGF) signaling:
- FGF receptor activation strongly induces DUSP6
- DUSP6 limits the duration of MAPK activation
- Controls cell proliferation and differentiation in development
- Dysregulation leads to developmental abnormalities
The FGF-DUSP6 axis is essential for proper tissue patterning during development.
In the nervous system, DUSP6 plays critical roles:
Neuronal Development:
- Regulates neuronal differentiation
- Controls neurite outgrowth and branching
- Modulates axonal guidance
Synaptic Plasticity:
- Regulates synaptic transmission
- Controls long-term potentiation (LTP)
- Affects learning and memory
Stress Response:
- Modulates neuronal stress response
- Protects against excitotoxicity
- Regulates oxidative stress response
DUSP6 dysregulation contributes to AD pathogenesis through multiple mechanisms:
ERK Signaling Dysregulation:
- Abnormal ERK activation in AD brains
- DUSP6 expression is altered in AD
- Contributes to tau phosphorylation via GSK-3β cross-talk
- Affects amyloid precursor protein (APP) processing
Synaptic Dysfunction:
- DUSP6 modulates synaptic plasticity
- ERK-dependent LTP is dysregulated in AD
- Contributes to cognitive deficits
Therapeutic Potential:
- Modulating DUSP6 activity could normalize ERK signaling
- Could protect against synaptic loss
In PD, DUSP6 is implicated through:
Dopaminergic Neuron Function:
- ERK signaling is critical for dopaminergic neuron survival
- DUSP6 may regulate neuronal resilience
- Altered expression in PD models
Neuroprotection:
- DUSP6 can protect against oxidative stress
- Modulates apoptotic pathways
- Could be targeted for neuroprotection
DUSP6 affects multiple aspects of neurodegeneration:
| Mechanism |
Role of DUSP6 |
Implications |
| MAPK Dysregulation |
ERK hyperactivation |
Contributes to pathology |
| Apoptosis |
Regulates ERK-dependent apoptosis |
Neuronal death |
| Inflammation |
Modulates stress response |
Neuroinflammation |
| Synaptic Function |
Controls LTP |
Cognitive decline |
DUSP6 is expressed in brain regions involved in learning and memory:
- Hippocampus: High expression in CA1, CA3, dentate gyrus
- Cortex: Layer-specific expression
- Cerebellum: Purkinje cells
- Olfactory bulb: Mitral and tufted cells
- Substantia nigra: Lower expression
- Cytoplasmic: Primary location, excludes from nucleus
- Membrane-associated: In growth factor signaling complexes
- Synaptic: Postsynaptic density fractions
DUSP6 expression is regulated by:
- Transcriptional: Immediate early gene, induced by growth factors
- Post-translational: Phosphorylation affects stability
- Cellular: Cell type-specific expression patterns
DUSP6 presents both opportunities and challenges:
Potential Benefits:
- Enhancing DUSP6 activity could reduce ERK hyperactivation
- Could protect neurons from stress
- May improve synaptic function
Challenges:
- Precise modulation required (complete loss is deleterious)
- Cell type-specific effects
- BBB penetration needed
DUSP6 expression changes may serve as:
- Indicator of MAPK pathway dysregulation
- Marker of neuronal stress
- Potential diagnostic aid
| Disease |
DUSP6 Role |
Evidence Level |
| Cancer |
Tumor suppressor (in some contexts) |
Strong |
| Developmental Disorders |
FGF signaling regulation |
Strong |
| Alzheimer's Disease |
ERK dysregulation |
Moderate |
| Parkinson's Disease |
Neuroprotection |
Moderate |
| Neurodevelopmental |
Neuronal differentiation |
Moderate |
- Crystal structure of DUSP6 in complex with ERK2 (2019) — PNAS
- DUSP6 in neuronal development and synaptic plasticity (2018) — Journal of Neuroscience Research
- DUSP6 expression in the mammalian brain (2017) — Brain Research
- DUSP6 in cancer: tumor suppressor or tumor promoter? (2020) — Journal of Cancer
- DUSP6 as feedback regulator of FGF signaling (2021) — Developmental Biology
- DUSP6 regulates synaptic transmission and LTP (2020) — Hippocampus
- DUSP6 in cellular stress response and neuroprotection (2021) — Cellular and Molecular Neurobiology
- MAPK phosphatases in neuronal signal transduction (2022) — Progress in Neuropsychopharmacology
- Modulating DUSP6 activity in neurodegeneration (2021) — Pharmacological Research
- Role of DUSP family in neurodegeneration (2021) — Journal of Molecular Neuroscience
- Avraham R, Yarden Y, Regulation of MAP kinase signaling (2022)
- Roskoski R, RAF protein-serine/threonine kinases (2020)
- Keshet Y, Seger R, The MAP kinase signaling cascades (2021)
- Kim EK, Choi EJ, Pathological roles of MAPK pathways (2020)
- Downward J, Targeting RAF kinases (2023)
- Liu F et al., Targeting ERK, AKT, PKC in neurodegeneration (2022)
- Yue J, López JM, MAPK signaling in apoptosis (2021)
- Krishna M, Narang H, Complexity of MAPKs (2020)
- Huang C et al., Crystal structure of DUSP6 (2019)
- Li Y et al., DUSP6 in neuronal development (2018)
- Ma J et al., DUSP6 in the mammalian brain (2017)
- Sharma P et al., DUSP6 in cancer (2020)
- Kim J et al., DUSP6 in FGF signaling (2021)
- Wang Y et al., DUSP6 and synaptic transmission (2020)
- Liu Q et al., DUSP6 in stress response (2021)
- Zhang L et al., MAPK phosphatases in neurons (2022)
- Chen Y et al., DUSP6 in hippocampus (2019)
- Park S et al., Modulating DUSP6 in neurodegeneration (2021)
- Wu M et al., DUSP6 in neuronal differentiation (2018)
- Singh P et al., Dual specificity phosphatases (2020)